Home › Urothelial (Transitional Cell) Carcinoma › Missouri › Kansas City

Urothelial (Transitional Cell) Carcinoma clinical trials in Kansas City, MO

4 studies for Urothelial (Transitional Cell) Carcinoma are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer

RecruitingPhase 3

University Health Truman Medical Center, Kansas City
University of Kansas Cancer Center - Briarcliff, Kansas City
University of Kansas Cancer Center - North, Kansas City
and 1 more

Ages 18 and older · All sexes · Updated Oct 5, 2026 · NCT06524544

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

RecruitingPhase 2

University Health Truman Medical Center, Kansas City
University of Kansas Hospital-Westwood Cancer Center, Westwood · 5 mi away

Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT03866382

An Open-label Study to Investigate the Efficacy and Safety of Dato-DXd + Rilvegostomig vs SoC in Adult Participants With High-risk MIUC

RecruitingPhase 3

Research Site, Kansas City

Ages 18 and older · All sexes · Updated Jul 22, 2026 · NCT07720284

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study

Massive Bio SYNERGY-AI site, Kansas City

All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

Urothelial (Transitional Cell) Carcinoma trials in other cities

Other studies in Kansas City

From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.